LENZ Therapeutics Files Q1 2025 10-Q
Ticker: LENZ · Form: 10-Q · Filed: May 7, 2025 · CIK: 1815776
| Field | Detail |
|---|---|
| Company | Lenz Therapeutics, Inc. (LENZ) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
TL;DR
LENZ Therapeutics filed its Q1 2025 10-Q. Financials and operations update.
AI Summary
LENZ Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Graphite Bio, Inc. and Integral Medicines, Inc., is involved in biological products. Their business address is in Solana Beach, California.
Why It Matters
This filing provides investors with an update on LENZ Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, LENZ Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Report Period End Date (The end of the fiscal quarter covered by the report.)
- 20250507 — Filing Date (The date the 10-Q was officially filed with the SEC.)
Key Players & Entities
- LENZ Therapeutics, Inc. (company) — Filer of the 10-Q
- Graphite Bio, Inc. (company) — Former name of LENZ Therapeutics
- Integral Medicines, Inc. (company) — Former name of LENZ Therapeutics
- 201 LOMAS SANTA FE DRIVE, SUITE 300 (address) — Business and mailing address
- SOLANA BEACH, CA (location) — City and State of business address
FAQ
What is the primary business of LENZ Therapeutics, Inc.?
LENZ Therapeutics, Inc. is involved in biological products, specifically within the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) industry, as indicated by SIC code 2836.
When did LENZ Therapeutics, Inc. change its name from Graphite Bio, Inc.?
The company changed its name from Graphite Bio, Inc. on March 12, 2021.
What is the fiscal year end for LENZ Therapeutics, Inc.?
The fiscal year end for LENZ Therapeutics, Inc. is December 31.
Where is LENZ Therapeutics, Inc. located?
LENZ Therapeutics, Inc. is located at 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA 92075.
What is the SEC file number for LENZ Therapeutics, Inc.?
The SEC file number for LENZ Therapeutics, Inc. is 001-40532.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding LENZ Therapeutics, Inc. (LENZ).